GlyCardial Diagnostics has completed patient recruitment in EDICA trial: a multicenter international clinical study for the early detection of Myocardial Ischaemia.
Category: #H2020
Post
Judit Cubedo has been selected as finalist for the EU Prize for Women Innovators 2020
We are honoured to announce that our CEO Judit Cubedo has been selected as finalist for the EU Prize for Women Innovators 2020!
Post
Prof. Juan Carlos Kaski as Chief Medical Officer of GlyCardial Diagnostics
GlyCardial Diagnostics incorporates Prof. Juan Carlos Kaski as Chief Medical Officer to oversee the Clinical Development.
Post
GlyCardial Diagnostics enrols the first patient in EDICA trial
GlyCardial Diagnostics starts the enrolment of patients in EDICA trial: a multicenter international clinical study for the early detection of Myocardial Ischaemia.
Post
GlyCardial Diagnostics receives funds from the H2020 Programme
GlyCardial Diagnostics receives 1.9M€ from the SME Instrument Phase II H2020 Programme to advance in the development of the novel test for the early detection of cardiac ischemia.